Macrophage migration inhibitory factor has emerged as a central regulator of tumor progression and immune evasion. Initially identified as an inflammatory cytokine, it is now understood as a multifunctional signaling molecule that integrates hypoxia, metabolic stress, oncogenic activation, and tumor microenvironmental remodeling across diverse malignancies. Through pathways involving cluster of differentiation 74, cluster of differentiation 44, and C-X-C motif chemokine receptor 4, macrophage migration inhibitory factor promotes proliferation, survival, angiogenesis, epithelial-mesenchymal transition, invasion, and metastatic competence. It also shapes the tumor microenvironment by enhancing suppressive myeloid infiltration, macrophage polarization, cluster of differentiation 8-positive T-cell exhaustion, regulatory T-cell accumulation, and impaired antigen presentation. These combined effects position macrophage migration inhibitory factor as an immunometabolic mediator linking chronic inflammation with malignant adaptation and therapeutic resistance. Elevated signaling is associated with poor prognosis and reduced response to chemotherapy, radiotherapy, targeted therapy, and immune checkpoint blockade. Overall, macrophage migration inhibitory factor represents a mechanistically important and translationally relevant target whose clinical value will depend on precise biomarker-guided therapeutic integration.

Cardiovascular diseases remain the primary driver of global mortality, with advanced age serving the most significant risk factor for their development and progression. Emerging evidence suggests that chronic infections can act as potent catalysts for cardiac decline by prematurely inducing aging phenotypes. Pathogens, including viruses, bacteria, and parasites, that evade host clearance establish a state of permanent inflammaging: a chronic, low-grade inflammatory milieu characterized by persistent cytokine signaling and leukocyte infiltration. This environment directly mirrors the sterile inflammation that drives natural senescence. Mechanistically, chronic infection subverts the heart's homeostatic pathways, triggering cardiomyocyte senescence through the dysregulation of mTOR signaling and the impairment of autophagy. These infections further drive mitochondrial dysfunction and the overproduction of reactive oxygen species (ROS), leading to oxidative DNA damage and metabolic exhaustion within the myocardium. On a structural level, immune subversion, via macrophage polarization and the induction of autoimmunity, accelerates left ventricular hypertrophy, myocardial remodeling, and interstitial fibrosis. By characterizing chronic infection as a modifiable driver of biological aging, we can prioritize anti-infective strategies as essential components of cardiovascular longevity and geriatric care.